Global "Atherectomy
devices Market" 2025 Industry
research report covers the industry overview with Marketplace Size, Share,
Development, futuristic cost, earnings, demand and distribution data. Its vast
repository offers an analytical summary of the marketplace that can help to the
new and existing player to take a significant decision.
In this report, we
thoroughly examine and analyse the Global market for Atherectomy devices so
that market participants can improve their business strategy and ensure
long-term success. This report provides players with useful information and
suggests result-based ideas to give them a competitive advantage in the global Atherectomy
devices industry. It will show how other players compete in the global Atherectomy
devices Market and explain the strategies you use to differentiate yourself
from other participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/atherectomy-devices-market-size/request-sample
The global atherectomy
devices market size was valued at USD 488.04 million in 2016 and is anticipated
to reach USD 894.69 million by 2025, with CAGR of 6.97% over the forecast
period. Increase in prevalence of Peripheral artery disease (PAD) and Deep vein
thrombosis (DVT) is expected to drive the market growth over the forecast
period. Increase in aging population in the US and in economically developed
countries resulting in high requirement of medical devices for chronic illness.
This is expected to escalate the market growth of Atherectomy devices. Major
factors such as rising life expectancy declining fertility rates play a major
role in market growth in the foreseeable future.
Change in lifestyle trends
and eating habits increase Consumption of cholesterol and fatty foods among
individuals and lack of exercise which has been a major reason for coronary
artery disease and high risk of heart attacks. Depending on the severity of the
health issue atherectomy devices are used in the surgery by the doctors.
Diabetes, high blood pressure, obesity and smoking causes the blood arteries to
marrow and limit the blood supply to the heart. It is estimated that 382
billion people throughout the world have diabetes. Environmental factors such
as foods, viruses, toxins and unbalanced work life play a role in development
of diabetes. Growing number of patients with these vascular diseases are
expected to proliferate the demand for atherectomy devices.
Adopting advanced
technology by using laser, ultraviolet radiation and recombinant issue
technology and 3D image generation provides a better scope for the market.
Added benefits such as minimal incisions, higher surgical restoration rate, low
postoperative complications increase more patients opting for atherectomy
devices. New technological advancements and the recent FDA approval of Two drug
coated balloons are increasing atherectomy procedural volume and driving growth
in the demand for atherectomy devices.
Recalls of medical devices
has been a major issue in pharmaceutical industry. Every device should maintain
the standard quality and safety measures set by the Food and Drug
Administration (FDA). All the manufacturing firms should ensure that the
products are safe and do not endanger the end consumer.
Athrectomy devices face a
tough competition from Catheter (Tornus) which has been developed for chronic
total occlusion recanalization. However, Catheter has a lower success rate of
only 77% as compared to the traditional atherectomy devices with 95%. Tornus
catheter is also associated with longer procedural duration time with 144 minutes
versus the atherectomy devices 115 minutes.
Lack of product
differentiation forms a major challenge in the atherectomy market. Most
companies trying to enter the market find it hard to overcome the product
differentiation because they require high investment and lack resources to
create products that can compete with the existing ones. High cost and limited
awareness in certain regions of the world act as a restraint for the market
growth.
Atherectomy technique is a
popular substitute for stents and angioplasty treatments. In stents and
angioplasty, the deposited plaque is pushed inside the blood vessel, however in
atherectomy the plaque is removed by using surgical methods. The technique has
advantages over the other methods by providing increased wound healing rate
The market has been
classified on the basis of its device functions such as rotational, orbital,
excimer laser, excisional, directional and Jetstream atherectomy. The largest
share of the market is occupied by orbital and directional atherectomy due to
minimal invasive treatment, blood flow restoration, reduction in procedure time
and application in more complex cases. Market players are coming with better
techniques and products to meet the requirement of the consumers.
The market is segmented on
the basis of geography such as North America, Europe, Asia pacific. North
America is the leading player in the market followed by Europe. Peripheral
artery disease affects nearly 10 million people and around 720,000 die every
year due to heart attack in US making it the potential market for the devices.
Higher number of surgeries are being performed in US and Europe due to better
awareness among people and also availability of resources making them the
leading regions in the market.
Asia pacific can be a
potential market for atherectomy devices since countries such as India and
china possess the largest number of cardiac patients with an annual incidence
of 7 million strokes. Tobacco consumption is rapidly increasing in south Asian
countries in conjunction with economic expansion increasing their risk of
artery diseases.
Reduction of abdominal
obesity through lifestyle measures can improve all components of the metabolic
syndrome and likely delay the development of both diabetes and atherosclerosis.
Beyond lifestyle intervention, optimal management of risk factors to
evidence-based targets is essential.
High awareness of health
problems caused due to change in lifestyle and optimal management of risk
factors can improve the metabolic syndrome and likely reduce the development of
both diabetes and atherosclerosis and hence reducing the demand for the
atherectomy devices.
The major companies of the
market include Bayer AG, Cardiovascular systems, St. Jude medical, Boston
scientific corporation, Abbott laboratories, C.R Bard Inc., Volcano
Corporation. The competition in this market usually depends on the technology
used in manufacturing of the devices and also the pricing strategies.
Medtronic’s is leading competitor in peripheral atherectomy devices. Medtronic
acquired Covedian in 2015 and is expected to remain in the leading position
however it will face increasing competition from cardiovascular systems Inc.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment